A Jacobs
About
In The Last Decade
A Jacobs
12 papers receiving 410 citations
Peers
Comparison fields: 5 of 49
- Hematology 240
- Molecular Biology 158
- Oncology 120
- Genetics 97
- Immunology 92
Countries citing papers authored by A Jacobs
This map shows the geographic impact of A Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Jacobs more than expected).
Fields of papers citing papers by A Jacobs
This network shows the impact of papers produced by A Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Jacobs. The network helps show where A Jacobs may publish in the future.
Co-authorship network of co-authors of A Jacobs
This figure shows the co-authorship network connecting the top 25 collaborators of A Jacobs. A scholar is included among the top collaborators of A Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Jacobs. A Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group. | 40 |
| 3 | Increased drug accumulation ex vivo with cyclosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein. | 17 |
| 4 | 81 | |
| 5 | 37 | |
| 6 | 167 | |
| 7 | Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group. | 5 |
| 8 | Enrichment of progenitor cells from human marrow. | 5 |
| 9 | 42 | |
| 10 | Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes. | 18 |
| 11 | Advances in red cell anomalies. | 1 |
| 12 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.